diagnostic criteria used for imaging interpretation; and true-positive, true-negative, false-positive, false-negative study results for the staging elements of myometrial invasion, cervical invasion, presence of extrauterine disease, and presence of lymph node metastasis. Any disagreements were resolved through consensus and consultation with a third reviewer. The reviewers were not blinded to the authors, journal or year of publication.
Methods of synthesis
How were the studies combined? Sensitivity and specificity were recalculated for each included study using the conventional corrections for zero counts (see Other Publications of Related Interest no.1). To compare the three imaging modalities, summary receiver operating characteristic (ROC) curves were constructed (see Other Publications of Related Interest nos.2-3), and the authors obtained corresponding Q* values (points on the summary curve where sensitivity and specificity are equal).
How were differences between studies investigated?
Summary ROC curves were constructed in all cases. In addition, the transformed data of all the included studies were combined through a robust regression (Huber M-regression) analysis (see Other Publications of Related Interest no.4) in a regression line.
Covariate adjustment analysis was also undertaken (see Other Publications of Related Interest no.2) using the following covariates: severity of disease, year of publication, results of methodologic quality rating, and subtype of imaging technique.
Results of the review
Forty-seven studies were included. Of these, one study compared CT with US and MRI, 2 studies compared MRI with US, and 2 studies compared MRI with CT. Subsets of data were obtained for the assessment of myometrial invasion in 42 studies (n=1,556), cervical invasion in 14 studies (n=536), extrauterine disease in 6 studies, and lymph node metastasis in 1 study. Due to the limited data, the studies investigating extrauterine disease and lymph node metastasis were excluded from the analysis. and MRI, the summary ROC curves showed no significant differences in performance. The comparison between MRI techniques showed significantly better results for contrast-enhanced versus non-enhanced MRI (p<0.001). Differences in the Q* values did reach statistical significance when contrast-enhanced imaging was compared with US (p=0.002). There was also a trend towards a higher diagnostic accuracy for contrast-enhanced MRI than for CT (p=0.18).
Cervical involvement.
The Q* values could only be calculated for MRI (0.92, 95% CI: 0.87, 0.95).
Authors' conclusions
Although US, CT or MRI can be used in the pre-treatment evaluation of endometrial cancer, contrast-enhanced MRI offers 'one-stop' examination with the highest efficacy.
